These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study. Salmerón Ríos S; Cortés Zamora EB; Avendaño Céspedes A; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Mas Romero M; Tabernero Sahuquillo MT; Blas Señalada JJ; Murillo Romero A; García Nogueras I; Estrella Cazalla JD; Andrés-Pretel F; Lauschke VM; Stebbing J; Abizanda P J Am Geriatr Soc; 2022 Mar; 70(3):650-658. PubMed ID: 34894403 [TBL] [Abstract][Full Text] [Related]
28. Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G. Hibino M; Watanabe S; Kamada R; Tobe S; Maeda K; Horiuchi S; Kondo T Intern Med; 2022 Mar; 61(6):811-819. PubMed ID: 34980798 [TBL] [Abstract][Full Text] [Related]
29. Protective effects of prior third dose mRNA vaccination in rural nursing home residents during SARS-CoV-2 outbreaks. Rhynold ES; Quan S; Orr PH; LaBine L; Singer A; St John PD J Am Geriatr Soc; 2022 Nov; 70(11):3245-3249. PubMed ID: 35938635 [TBL] [Abstract][Full Text] [Related]
30. Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital. Palomo-Palomo C; Guerra-Estévez D; Parrado-González A; Estaire-Gutiérrez J; Reyes-Malia M; Romero-Alonso MM Farm Hosp; 2022 Mar; 46(3):152-156. PubMed ID: 36183208 [TBL] [Abstract][Full Text] [Related]
31. Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents. Tuaillon E; Pisoni A; Veyrenche N; Rafasse S; Niel C; Gros N; Muriaux D; Picot MC; Aouinti S; Van de Perre P; Bousquet J; Blain H Sci Rep; 2022 Aug; 12(1):13749. PubMed ID: 35962053 [TBL] [Abstract][Full Text] [Related]
32. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers. Nachtigall I; Bonsignore M; Hohenstein S; Bollmann A; Günther R; Kodde C; Englisch M; Ahmad-Nejad P; Schröder A; Glenz C; Kuhlen R; Thürmann P; Meier-Hellmann A BMC Infect Dis; 2022 Mar; 22(1):291. PubMed ID: 35346089 [TBL] [Abstract][Full Text] [Related]
34. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection. Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492 [TBL] [Abstract][Full Text] [Related]
35. Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study. Barin B; Kasap U; Selçuk F; Volkan E; Uluçkan Ö Lancet Microbe; 2022 Apr; 3(4):e274-e283. PubMed ID: 35165669 [TBL] [Abstract][Full Text] [Related]
36. Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan. Kitagawa H; Kaiki Y; Sugiyama A; Nagashima S; Kurisu A; Nomura T; Omori K; Akita T; Shigemoto N; Tanaka J; Ohge H J Infect Chemother; 2022 Apr; 28(4):576-581. PubMed ID: 35058126 [TBL] [Abstract][Full Text] [Related]
37. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan. Kageyama T; Ikeda K; Tanaka S; Taniguchi T; Igari H; Onouchi Y; Kaneda A; Matsushita K; Hanaoka H; Nakada TA; Ohtori S; Yoshino I; Matsubara H; Nakayama T; Yokote K; Nakajima H Clin Microbiol Infect; 2021 Dec; 27(12):1861.e1-1861.e5. PubMed ID: 34375755 [TBL] [Abstract][Full Text] [Related]
38. Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine. Levy I; Levin EG; Olmer L; Regev-Yochay G; Agmon-Levin N; Wieder-Finesod A; Indenbaum V; Herzog K; Doolman R; Asraf K; Halperin R; Lustig Y; Rahav G Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016109 [TBL] [Abstract][Full Text] [Related]
39. Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents. Van Praet JT; Vandecasteele S; De Roo A; De Vriese AS; Reynders M Clin Infect Dis; 2021 Dec; 73(11):2145-2147. PubMed ID: 33825869 [No Abstract] [Full Text] [Related]
40. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents. Lafuente-Lafuente C; Rainone A; Guérin O; Drunat O; Jeandel C; Hanon O; Belmin J; Gerontology; 2022; 68(12):1384-1392. PubMed ID: 35313315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]